AU
The words “Research Use Only”, often shortened to RUO, appear on many products supplied for laboratory and analytical work. It sounds straightforward, but the phrase can easily be misunderstood, particularly when it appears on peptide products.
So, what does it actually tell you?
What “Research Use Only” means
In a laboratory setting, Research Use Only generally indicates that a material is being supplied for research, testing or analytical purposes rather than for use as a medicine or treatment.
For peptide materials, this might involve controlled laboratory work such as analytical testing, method development, chemical characterisation or other research activities.
An RUO label should therefore be read as information about the product’s stated intended use. It should not be interpreted as directions for personal or therapeutic use.
What it does not mean
This is where the distinction matters.
Putting “Research Use Only” on a label does not automatically determine the regulatory status of a product in Australia.
The Therapeutic Goods Administration (TGA) looks at factors including what a product contains, how it is presented, the claims made about it and its intended purpose when determining whether it is regulated as a therapeutic good.
The TGA has also made clear that disclaimers such as “Research Use Only” or “not for human use” do not, by themselves, change whether a product is regulated as a therapeutic good. Nor does an RUO statement automatically remove legal requirements relating to matters such as importation, supply or advertising.
In other words, RUO is not a shortcut around Australian therapeutic goods regulation.
RUO is not the same as TGA approval
Another important distinction is between an RUO-labelled material and a therapeutic product included in the Australian Register of Therapeutic Goods (ARTG).
A research label should never be taken to mean that the TGA has reviewed or approved that particular product for human therapeutic use.
Where a therapeutic good is not included in the ARTG, it is generally considered an unapproved therapeutic good unless a relevant exemption, approval or authority applies. The TGA states that unapproved therapeutic goods have not been assessed by it for safety, quality or effectiveness.
Why the wording matters
Clear terminology helps researchers understand what a supplier is actually representing about a material.
Rather than treating “Research Use Only” as a broad assurance, look at the information behind the product: its identity, batch documentation, analytical results, storage information and stated purpose.
For Australian researchers, the useful distinction is simple: RUO describes an intended research context. It does not, by itself, establish regulatory approval, therapeutic suitability or an exemption from Australian law.
Where regulatory status is important, refer to current TGA guidance rather than relying on the wording printed on a product label.
